Cannabinoid compositions and uses
US10413521B2 · kind B2 · utility
8Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2015 |
| Grant date | Sep 17, 2019 |
| Priority date | — |
| Expiry date | Aug 13, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2202/0468
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An inhalable composition for use as a medicament in the treatment of a subject wherein said composition comprises: one or more cannabinoids or a pharmaceutically acceptable derivative or salt thereof; a propellant; a monohydric or polyhydric alcohol; and a glycol and/or glycol ether, characterized in that the ratio of monohydric or polyhydric alcohol to glycol or glycol ether by weight is from 6:1 to 1:1, wherein the composition is administered in the form of an aerosol having a fine particle fraction of 60% or more.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.